{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Manhattan",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA021301"
        ],
        "brand_name": [
          "LEVOXYL"
        ],
        "generic_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "product_ndc": [
          "60793-850",
          "60793-851",
          "60793-852",
          "60793-853",
          "60793-854",
          "60793-855",
          "60793-856",
          "60793-857",
          "60793-858",
          "60793-859",
          "60793-860"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "rxcui": [
          "892246",
          "892251",
          "966157",
          "966164",
          "966170",
          "966175",
          "966184",
          "966190",
          "966194",
          "966200",
          "966204",
          "966211",
          "966220",
          "966221",
          "966222",
          "966224",
          "966225",
          "966248",
          "966249",
          "966253",
          "966270",
          "966283"
        ],
        "spl_id": [
          "e230c170-2a16-47d0-bce7-ac0414c192f7"
        ],
        "spl_set_id": [
          "758588c3-c63e-491b-0aa2-4f50d80cb174"
        ],
        "package_ndc": [
          "60793-850-10",
          "60793-850-01",
          "60793-851-10",
          "60793-851-01",
          "60793-852-10",
          "60793-852-01",
          "60793-853-10",
          "60793-853-01",
          "60793-854-10",
          "60793-854-01",
          "60793-855-10",
          "60793-855-01",
          "60793-856-10",
          "60793-856-01",
          "60793-857-10",
          "60793-857-01",
          "60793-858-10",
          "60793-858-01",
          "60793-859-10",
          "60793-859-01",
          "60793-860-10",
          "60793-860-01"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0360793856018",
          "0360793850016",
          "0360793852010",
          "0360793851013",
          "0360793857015",
          "0360793853017",
          "0360793854014",
          "0360793858012",
          "0360793855011",
          "0360793859019",
          "0360793860015"
        ],
        "unii": [
          "9J765S329G"
        ]
      },
      "product_type": "Drugs",
      "event_id": "97334",
      "recalling_firm": "Pfizer",
      "address_1": "66 Hudson Blvd",
      "address_2": "N/A",
      "postal_code": "10001",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Within U.S",
      "recall_number": "D-0575-2025",
      "product_description": "Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.",
      "product_quantity": "29, 004 bottles",
      "reason_for_recall": "Subpotent drug",
      "recall_initiation_date": "20250729",
      "center_classification_date": "20250808",
      "report_date": "20250820",
      "code_info": "Lot #: 24C11, Exp 2/28/2026.",
      "more_code_info": ""
    }
  ]
}